1. Brunton LL, Chabner BA, Knollmann BC, editors. Analgesic-antipyretic and anti-inflammatory agents: pharmacotherapy of gout. In: Goodman & Gilman’s the pharmacological basis of therapeutics. 12th ed. New York: Mc Graw-Hill Professional; 2010. p. 434–6.
2. Furst DE, Ulrich RW, Prakash S. Nonsteroidal anti-inflammatory drugs, disease-modifying antirheumatic drugs, nonopioid analgesics, and drugs used in gout. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and clinical pharmacology. 12th ed. New York: Mc Graw-Hill Professional; 2012. p. 636–8.
3. Jamali F, Brocks DR. Clinical pharmacokinetics of ketoprofen and its enantiomers. Clin Pharmacokinet. 1990;19:197–217.
4. Jamali F, Russell AS, Foster RT, Lemko C. Ketoprofen pharmacokinetics in humans: evidence of enantiomeric inversion and lack of interaction. J Pharm Sci. 1990;79:460–1.
5. Shi D, Jin Y, Tang Y, Hu H, Xu S, Yu L, Jiang H, Zeng S. Stereoselective binding of mexiletine and ketoprofen enantiomers with human serum albumin domains. Acta Pharmacol Sin. 2012;33:710–6.